Interest of Intravaginal Electro-stimulation at Home by GYNEFFIK® Compared to Usual Care in Incontinent Patients With Prior Perineal Reeducation
NCT ID: NCT02029027
Last Updated: 2014-01-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
163 participants
INTERVENTIONAL
2012-08-31
2014-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pelvic Floor Muscle Training With and Without Biofeedback in Women With Stress Urinary Incontinence
NCT02275728
Comparing Use of a Digital Health System of Pelvic Floor Exercise Program to Kegel Exercises in Stress Urinary Incontinence
NCT03632447
Prospective and Comparative Evaluation of a Medical Device Composed of a Perineal Probe Connected to a Mobile Application in the Management of Stress Urinary Incontinence.
NCT06285292
Effect of Peri-Urethral Stimulation on Intra-Urethral Pressure
NCT05900570
TVT-SECUR A Pilot Study for the Treatment of Stress Urinary Incontinence
NCT00463554
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
GYNEFFIK(R)
30 min-session of vaginal electro-stimulation by GYNEFFIK thrice a week for 6 months (except during menstrual periods)
GYNEFFIK(R)
Vaginal electro-stimulation medical device
Usual Care
Any treatment / physiotherapy sessions / muscular training ... usually recommended and/or prescribed by the patient's general practitioner or gynaecologist with the exception of vaginal electro-stimulation
Usual Care
Any treatment / physiotherapy sessions / muscular training ... usually recommended and/or prescribed by the patient's general practitioner or gynaecologist with the exception of vaginal electro-stimulation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
GYNEFFIK(R)
Vaginal electro-stimulation medical device
Usual Care
Any treatment / physiotherapy sessions / muscular training ... usually recommended and/or prescribed by the patient's general practitioner or gynaecologist with the exception of vaginal electro-stimulation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* seen for urinary stress incontinence or urinary mixed incontinence (with a major stress incontinence part) troubles
* spontaneously asking for help
* who can be followed for a long time
Exclusion Criteria
* Urinary troubles due to neurological pathology (stroke, multiple sclerosis, ...)
* UI due to congenital malformation
* UI having led to surgery
* UI treated in the last 6 months
* UI within 24 weeks of Past Partum
* Pelvic surgery within 12 months
* On-going inflammatory or infectious neoplastic disease
* Perineal hypoesthesia
* Local conditions prohibiting the use of an intra-vaginal device (vaginal atrophia, continuous metrorrhagia, vaginal prolapse \> 2°, ...)
* Pacemaker use
* Women of child bearing potential without effective method of contraception or planning to get pregnant in the next 12 months
* Intravaginal contraception
* Mental impairment or inability to understand or follow study instructions
* Patient who may not come back to the study visits
* Patient already enrolled for another study or having been enrolled in another clinical study in the past 3 months
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Effik
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marc Bernardini, MD
Role: PRINCIPAL_INVESTIGATOR
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Marc Bernardini
Marseille, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2012-A00235-38
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.